September 10 & 11, 2012 | Boston, Massachusetts
Primary care physicians, endocrinologists, and cardiologists will find this summit valuable in their daily practice.
After completing this activity, participants will be able to:
- Discuss current and evolving perspectives on the pathophysiology of diabetes and the cardiometabolic syndrome, and how they contribute to cardiovascular risk and disease;
- Identify the components of the cardiometabolic syndrome, their clinical definitions, and their targeted treatment goals.
- Design diabetes treatments utilizing the evidence-based perspectives derived from both the ADA and AACE treatment recommendations;
- Use data and clinical assessment parameters to determine an appropriate weight management program for patients, including both surgical and medical approaches;
- Review lipid and blood pressure therapy as it applies to CVD risk reduction including controversies in lipid management and novel hypertension treatment strategies;
- Describe protocols for cardiovascular evaluation and diagnosis in the person with components of the cardiometabolic syndrome;
- Describe unique clinical characteristics and treatment concerns of coronary artery disease and congestive heart failure in people with diabetes.
Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Joslin Diabetes Center designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits.TM Physicians should only claim credit commensurate with the extent of their participation in the activity.
This CME activity was planned and produced in accordance with ACCME Essentials.
Participants not eligible for continuing medical education credit will receive a certificate of participation.
It is the policy of Joslin Diabetes Center to ensure fair balance, independence, objectivity, and scientific rigor in all activities. All faculty participating in CME activities sponsored by Joslin Diabetes Center are required to present evidence-based data, identify and reference off-label product use, and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.
Page last updated: April 24, 2017